MRF Meets with FDA on State of Melanoma Drug Development
November 23, 2010The Melanoma Research Foundation (MRF) met on November 15, 2010 with high-level officials at the Food and Drug Administration (FDA), including Dr. Richard Pazdur, the Director of the Office of Oncology Drug Products. The Melanoma Research Founda …
In Memory of Jenna Bockmiller
November 9, 2010Over the weekend the melanoma community lost a true fighter. Jenna Bockmiller of California died at the age of 20, after a 6-year battle with melanoma.Her tenacious fight against this disease inspired many in the patient community and each of us …
5 Questions That May Help You Dodge Cancer
November 8, 2010WASHINGTON— With growing financial and time pressures in medical care, the era of the leisurely doctor’s visit is largely gone. As visits become increasingly compact, it’s more important than ever for patients to go in prepared …
Promising Phase II Results for New Drug to Treat Advanced Melanoma
November 5, 2010Roche announced results from a Phase II clinical study of RG7204 (PLX4032), an inhibitor targeting the BRAF protein that is found in half of metastatic melanoma tumors. The promising data was presented at the seventh International Melanoma Resear …
FDA Extends Deadline for Decision on Ipilimumab
November 3, 2010The U.S Food and Drug Administration (FDA) extended its deadline for an approval decision on Bristol-Myers Squibb’s (BMS) drug for advanced melanoma, ipilimumab. The FDA was expected to reach a decision by December 25, 2010 but has delayed …
Recent Comments